Royal Bank of Canada
BCAB icon

Royal Bank of Canada’s BioAtla BCAB Stock Holding History

Royal Bank of Canada’s Portfolio BCAB Stock Details BCAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-18
Closed – – 7023
2025
Q1 		$0 Sell
18
-71
-80% -$1.52K ﹤0.01% 6810
2024
Q4 		$3K Buy
89
+88
+8,800% +$7.38K ﹤0.01% 6627
2024
Q3 		$0 Sell
1
-59
-98% -$4.95K ﹤0.01% 6846
2024
Q2 		$4K Buy
60
+32
+114% +$3.81K ﹤0.01% 6568
2024
Q1 		$4K Sell
28
-234
-89% -$29.1K ﹤0.01% 6483
2023
Q4 		$32K Buy
262
+6
+2% +$520 ﹤0.01% 6161
2023
Q3 		$22K Buy
256
+163
+175% +$20.8K ﹤0.01% 6138
2023
Q2 		$14K Buy
+93
New +$16K ﹤0.01% 6344
2023
Q1 		– Sell
-1
Closed -$180 – 7069
2022
Q4 		$0 Hold
1
– – ﹤0.01% 7214
2022
Q3 		$0 Buy
+1
New +$327 ﹤0.01% 7435
2022
Q2 		– Sell
-19
Closed -$3.02K – 7364
2022
Q1 		$5K Sell
19
-46
-71% -$19.2K ﹤0.01% 7238
2021
Q4 		$63K Buy
65
+39
+150% +$49.9K ﹤0.01% 6230
2021
Q3 		$38K Buy
26
+9
+53% +$17.5K ﹤0.01% 6319
2021
Q2 		$35K Sell
17
-5
-23% -$11.3K ﹤0.01% 6256
2021
Q1 		$55K Buy
+22
New +$56.4K ﹤0.01% 5818

Other funds holding BCAB

ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Royal Bank of Canada's BCAB Position: Q2 2025 in Review

Royal Bank of Canada sold out of BioAtla (BCAB) in Q2 2025, closing a stake of 18 shares.

Royal Bank of Canada first reported a position in BCAB in Q1 2021 and held it in 15 quarters. The position peaked at $63K in Q4 2021. 39 funds tracked by Wall St. Rank hold BCAB as of Q2 2025.

  • Royal Bank of Canada reported no remaining BioAtla position as of Q2 2025 after selling out during the quarter.
  • Royal Bank of Canada sold 18 BioAtla shares in Q2 2025.
  • Royal Bank of Canada first reported a position in BioAtla in Q1 2021 and held it in 15 quarters.
  • Royal Bank of Canada's BioAtla position peaked at $63K in Q4 2021.
  • 39 funds tracked by Wall St. Rank held BioAtla as of Q2 2025.

Based on Royal Bank of Canada's 13F filing for Q2 2025, filed 14 Aug 2025.